VBIVQ — VBI Vaccines Share News
0.000.00%
Last trade - 00:00- $0.01m
- $36.16m
- $8.68m
Brief: Vbi Vaccines Announces New Tumor Response Data From Ongoing Randomized Controlled Phase 2B Study Of Vbi-1901 In Recurrent Glioblastoma Patients
VBI Vaccines Inc reports results for the quarter ended in March - Earnings Summary
Brief: VBI Vaccines Says Entered At Market Offering Deal For Gross Proceeds Of Up To $8.5 Mln
Brief: VBI Vaccines Q1 Adjusted EPS USD -0.55
VBI Vaccines Inc expected to post a loss of 53 cents a share - Earnings Preview
Brief: Perceptive Advisors Reports 4.4% Stake In Vbi Vaccines As Of April 16 - SEC Filing
VBI Vaccines Inc reports results for the quarter ended in December - Earnings Summary
Brief: VBI Vaccines Presents Encouraging Early Tumor Response Data From Randomized Controlled Phase 2b Study Of VBI-1901 In Recurrent Glioblastoma
Brief: VBI Vaccines Announces Expanded Strategic Partnership With Canadian Government To Advance mRNA-Launched eVLP (MLE) Vaccine Platform
VBI Vaccines Inc expected to post a loss of 22 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-CME Group, Robinhood Markets, Citigroup
VBI Vaccines rises on new license agreement
Brief: VBI Announces Agreement To Sell Manufacturing Capabilities, Enter Into License Agreement With Brii Biosciences
Brief: VBI Vaccines Says Co, Co's Unit And Lenders Agreed To Extend Forbearance Period Through And Including Jan 9, 2024
Brief: VBI Vaccines Q3 Adjusted EPS USD -0.38
Brief: VBI Vaccines Expands Proprietary Technology Platforms With Development Of Novel mRNA-Launched eVLP Vaccine Program
U.S. STOCKS ON THE MOVE-Nucor, Liberty Energy, Micron Technology
U.S. STOCKS ON THE MOVE-SoundHound, Tesla, Energy firms
U.S. STOCKS ON THE MOVE-VBI Vaccine, Precision BioSciences, American Battery Technology